摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid methyl ester | 1198074-66-6

中文名称
——
中文别名
——
英文名称
2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid methyl ester
英文别名
methyl N-{[2'-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)biphenyl-4-yl]methyl}-N-pentanoyl-L-valinate;methyl (2S)-2-[[4-[2-(4,4-dimethyl-5H-1,3-oxazol-2-yl)phenyl]phenyl]methyl-pentanoylamino]-3-methylbutanoate
2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid methyl ester化学式
CAS
1198074-66-6
化学式
C29H38N2O4
mdl
——
分子量
478.632
InChiKey
UHHVIKMJRVBXLF-SANMLTNESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    35
  • 可旋转键数:
    11
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    68.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid methyl ester吡啶三氯氧磷 作用下, 以90%的产率得到N-[(2'-氰基联苯-4-基)甲基]-N-(1-氧代戊基)-L-缬氨酸甲酯
    参考文献:
    名称:
    Convenient Synthesis of Valsartan via a Suzuki Reaction
    摘要:
    本文介绍了血管紧张素 II 抑制剂缬沙坦(Diovan)的高效合成方法。芳基芳基键的形成是其合成的关键步骤,该步骤是通过硼酸芳基酯与 2-溴苯基噁唑啉的铃木偶联完成的,具有良好的收率和纯度。这种方法克服了以前报道的合成方法的许多缺点。
    DOI:
    10.3184/030823410x12698758703526
  • 作为产物:
    描述:
    2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-amino}-3-methyl-butyric acid methyl ester戊酰氯吡啶 作用下, 以 二氯甲烷 为溶剂, 以90%的产率得到2-{[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid methyl ester
    参考文献:
    名称:
    Improved Synthesis of Valsartan via Nucleophilic Aromatic Substitution on Aryloxazoline
    摘要:
    A highly efficient approach to the synthesis of the angiotensin II receptor antagonist valsartan (Diovan), one of the most important agents used in antihypertensive therapy today is described. The formation of the aryl-aryl bond represents the key step of its synthesis, which has been done by simple nucleophelic aromatic substitution on aryloxazoline with good yield and purity.
    DOI:
    10.1080/00397910902840819
点击查看最新优质反应信息

文献信息

  • PREPARATION OF GRIGNARD REAGENTS USING A FLUIDIZED BED
    申请人:DPX HOLDINGS B.V.
    公开号:US20160137669A1
    公开(公告)日:2016-05-19
    The present invention relates to a process of preparing a Grignard reagent comprising reacting magnesium particulates in a fluid bed reactor. The present invention further relates to a continuous process comprising fluidizing magnesium particulates in a reactor, forming the Grignard reagent continuously, and reacting the Grignard reagent with a substrate.
  • US9550797B2
    申请人:——
    公开号:US9550797B2
    公开(公告)日:2017-01-24
  • Convenient Synthesis of Valsartan via a Suzuki Reaction
    作者:Samir Ghosh、A. Sanjeev Kumar、G. N. Mehta
    DOI:10.3184/030823410x12698758703526
    日期:2010.4

    An efficient synthesis of the angiotensin II inhibitor Valsartan (Diovan) is presented. The formation of the aryl–aryl bond represents the key step of its synthesis, which has been done by a Suzuki coupling of aryl boronate with 2-bromophenyl oxazoline with good yield and purity. This method overcomes many of the drawbacks associated with the previously reported syntheses.

    本文介绍了血管紧张素 II 抑制剂缬沙坦(Diovan)的高效合成方法。芳基芳基键的形成是其合成的关键步骤,该步骤是通过硼酸芳基酯与 2-溴苯基噁唑啉的铃木偶联完成的,具有良好的收率和纯度。这种方法克服了以前报道的合成方法的许多缺点。
  • Improved Synthesis of Valsartan via Nucleophilic Aromatic Substitution on Aryloxazoline
    作者:Samir Ghosh、A. Sanjeev Kumar、R. Soundararajan、G. N. Mehta
    DOI:10.1080/00397910902840819
    日期:2009.10.12
    A highly efficient approach to the synthesis of the angiotensin II receptor antagonist valsartan (Diovan), one of the most important agents used in antihypertensive therapy today is described. The formation of the aryl-aryl bond represents the key step of its synthesis, which has been done by simple nucleophelic aromatic substitution on aryloxazoline with good yield and purity.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物